 |
|
Alireza Abazari, PhD
University of Alberta, 2010
My current research interests include studying long-term preservation of cells and tissues by cryo and anhydrobiotic methods. I investigate the underlying damage mechanisms to trehalose-loaded cells during dehydration, desiccation and rehydration |
 |
|
Shyam Sundhar Bale, PhD
Rensselaer Polytechnic Institute, 2010
My primary research is to develop a microfluidic platform for real-time detection of cellular secretions. This technology will be combined with the living cell array so that we can simultaneously monitor gene expression and protein secretion. |
 |
|
Tim Berendsen, MD
University of Utrecht, 2009
I am working to develop a supercooling strategy for storing livers for extended periods of time at sub zero temperatures. I aim to understand the fundamental mechanisms of such storage and to extend the viable storage time for isolated liver grafts to several days. |
 |
|
Abhinav Bhushan, PhD
Louisiana State University, 2006
My main research interest is to develop in vitro microfluidic models of human diseases, including dermal contact hypersensitivity. Another is to develop strategies for sensitive detection of biomolecules as early indicators of diseases for more effective diagnosis. |
 |
|
Stefan Bohr, MD, PhD
Albert-Ludwigs Universitaet Freiburg, Germany, 2003
My research is aimed at understanding and promoting mechanisms of wound-healing to help develop new concepts in wound treatment. This includes new strategies to prevent colonization and systemic invasion by opportunistic bacteria as seen in severe burn injury. |
 |
|
Chihchen Chen, PhD
U Washington, 2006
I am working on developing microfluidic devices to study gene expression profiles that are affected by cryopreservation procedures. I also collaborate with Drs. He and Edd on microfluidic devices for cryopreservation. |
 |
|
Hansang Cho, PhD
UC Berkeley, 2010
My research focuses on studying cellular interactions and migration using microfluidic platforms. Specifically, I am working on microglia-neuron interaction in the context of Alzheimer’s disease and monocyte-neutrophil interaction during inflammation. |
 |
|
Salil Desai, PhD
MIT, 2010 |
 |
|
Marta Fernandez Suarez, PhD
MIT, 2008
I am working on the development of a rapid, point-of-care (POC) device to diagnose tuberculosis (TB) in resource-limited settings. The device combines the use of microfluidics for sample preparation and a miniaturized nuclear magnetic resonance for detection. |
 |
|
Alex Golberg, PhD
Hebrew University of Jerusalem, 2011
I am developing wound healing therapies. My research goal is to identify processes that lead to scarless tissue regeneration and to apply multitarget therapies to prevent scarring. I use non-thermal irreversible electroporation injury model to understand and quantify skin regeneration with reduced hypertrophic scars. |
 |
|
Yun Seok Heo, PhD
U Michigan, 2008
I’m interested in developing novel microfluidic systems for the cryopreservation and analysis of human oocytes and mammalian cells. My current research also focuses on developing universal tools for preservation of circulating tumor cells in cancer patients. |
 |
|
Anh N. Hoang, PhD
My research goals are to develop a microfluidic platform for the concentration
of tuberculosis (TB)from sputum samples for point of care detection and to
amplify the capture efficiency of circulating tumor cells(CTC) using a dendrimer
approach. |
 |
|
Maria-Louisa Izamis, PhD
MIT, 2010
I am developing methodology to reengineer discarded donor organs into transplantable grafts. Our ex vivo liver perfusion system provides a window of opportunity in which to objectively assess and improve organ viability so that even marginal organ can be transplanted. |
|
|
Caroline Jones, PhD
UC Davis, 2010 |
|
|
Yeonhee Kim, PhD
Virginia Tech, 2010 |
 |
|
Jungwoo Lee, PhD
U Michigan, 2009
I am developing ex vivo human bone marrow and lymph node tissue model systems combining microfluidics and 3D cell culture matrices. I am also working on modulating body’s immune responses utilizing messenchyaml stem cells and engineered microparticles. |
 |
|
William McCarty, PhD
University of California – San Diego, 2012
My main interests are in how fluid and macromolecular transport processes direct cell metabolism. I study hepatic zonation, intercellular transport through gap junctions, and work with the Microphysiological Systems group developing a microfluidic liver to predict drug metabolism. |
 |
|
I. Emre Ozkumur, PhD
Boston University, 2009
I am developing microfluidic devices for rapid isolation of circulating tumor cells from whole blood. Inertial focusing in fast flowing fluidics and magnetics are used for positive selection of rare specific cells or negative depletion of background cells. |
 |
|
Suraj Patel, PhD
MIT, 2010
I am currently working on a project the aim of which is to develop hepatotoxicity treatments by using inhibition of gap junction communication as the vehicle. A portion of my effort is dedicated to high throughput screens of novel gap junction inhibitors from large chemical libraries. |
 |
|
Sinem Perk, PhD
IIT, 2010
I am working on the metabolic modeling of hepatic hypermetabolism and ischemic injury with computational tools to explore the dynamics of liver metabolism and develop methodologies to alleviate hypermetabolism, or improve organ viability for transplantation. |
 |
|
Gavrielle Price, PhD
Boston University, 2010
My work focuses on engineering functional liver tissue for implantation. This project involves optimizing the recellularization of acellular liver scaffolds to improve their implantability and exploring biomaterials for differentiating embryonic stem cells into hepatocytes. |
 |
|
Nima Saeidi, PhD
Northeastern University, 2010
I am studying the cellular and molecular mechanisms underlying significant weight loss and alleviation of diabetes following Roux-en-Y gastric bypass surgery in rodents. I am also using organ decellularization methods to create novel scaffolds for hepatocyte cultures. |
 |
|
Keyue Shen, PhD
Columbia University, 2010
My current research is on developing engineered tumor models to study tumor-stroma interactions. I am interested in understanding the role of these interactions in tumor's resistance to various treatments, in order to eventually improve anti-cancer therapeutics. |
 |
|
Berk Usta, PhD
University of Florida, 2007
I am developing cell, tissue and organ preservation technologies. My main goal is to extend the current storage times achievable with traditional chemicals and preservation techniques. I also use microfluidic devices to quantify cell viability after preservation. |
 |
|
Ian Wong, PhD
Stanford University, 2010
I am developing microfluidic lab-on-a-chip platforms to investigate the chemotaxis of cancer cells and leukocytes. |
